Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025

Core Viewpoint - Standard BioTools Inc. is set to report its fourth quarter and full year 2024 financial results on February 26, 2025, after market close, followed by a conference call to discuss these results and operational progress [1][2]. Company Overview - Standard BioTools Inc. (Nasdaq: LAB) offers a portfolio of next-generation technologies aimed at accelerating biomedical research and improving patient outcomes. The company utilizes proprietary technologies such as SomaScan, mass cytometry, and microfluidics [3]. - The company collaborates with various sectors including academic, government, pharmaceutical, biotechnology, and clinical laboratories, focusing on critical areas in translational and clinical research like oncology, immunology, and immunotherapy [3].